12 minute read
Mar. 18, 2024
Omaveloxolone (SKYCLARYS): A Billion-Dollar Natural Product-Derived Reversible Covalent Nrf2/KEAP1 Modulator
omaveloxolone
oral, once-daily Nrf2 activator approved to treat Friedreich's ataxia from modification of oleanoic acid Biogen/Reata Acquisition, July 28, 2023 Reata Pharma, TX / Biogen, MA
Loading...
